BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35294486)

  • 1. 18F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules.
    Paez R; Shah C; Cords AJ; Muterspaugh A; Helton JE; Antic S; Eisenberg R; Chen H; Grogan EL; Manning HC; Walker RC; Massion PP
    PLoS One; 2022; 17(3):e0265427. PubMed ID: 35294486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer.
    Walker R; Deppen S; Smith G; Shi C; Lehman J; Clanton J; Moore B; Burns R; Grogan EL; Massion PP
    PLoS One; 2017; 12(2):e0171301. PubMed ID: 28182730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
    Mittra ES; Koglin N; Mosci C; Kumar M; Hoehne A; Keu KV; Iagaru AH; Mueller A; Berndt M; Bullich S; Friebe M; Schmitt-Willich H; Gekeler V; Fels LM; Bacher-Stier C; Moon DH; Chin FT; Stephens AW; Dinkelborg LM; Gambhir SS
    PLoS One; 2016; 11(2):e0148628. PubMed ID: 26890637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
    Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
    Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
    Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
    Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Wardak M; Sonni I; Fan AP; Minamimoto R; Jamali M; Hatami N; Zaharchuk G; Fischbein N; Nagpal S; Li G; Koglin N; Berndt M; Bullich S; Stephens AW; Dinkelborg LM; Abel T; Manning HC; Rosenberg J; Chin FT; Gambhir SS; Mittra ES
    Radiology; 2022 Jun; 303(3):620-631. PubMed ID: 35191738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective comparison of (4S)-4-(3-
    Cheng MF; Huang YY; Ho BY; Kuo TC; Hsin LW; Shiue CY; Kuo HC; Jeng YM; Yen RF; Tien YW
    Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):810-820. PubMed ID: 30635754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of diffusion-weighted imaging versus 18F-FDG PET/CT in differentiating pulmonary lesions: an updated meta-analysis of comparative studies.
    Liu J; Xia X; Zou Q; Xie X; Lei Y; Wan Q; Li X
    BMC Med Imaging; 2023 Mar; 23(1):37. PubMed ID: 36899303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy.
    Spadafora M; Evangelista L; Fiordoro S; Porcaro F; Sicignano M; Mansi L
    Curr Radiopharm; 2020; 13(3):243-248. PubMed ID: 32186274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
    Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
    AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting Pulmonary Nodules in Lung Cancer Patients Using Whole Body FDG PET/CT, High-resolution Lung Reformat of FDG PET/CT, or Diagnostic Breath Hold Chest CT.
    Flavell RR; Behr SC; Mabray MC; Hernandez-Pampaloni M; Naeger DM
    Acad Radiol; 2016 Sep; 23(9):1123-9. PubMed ID: 27283073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indeterminate pulmonary nodules on CT images in breast cancer patient: the additional value of 18F-FDG PET/CT.
    Evangelista L; Panunzio A; Cervino AR; Vinante L; Al-Nahhas A; Rubello D; Muzzio PC; Polverosi R
    J Med Imaging Radiat Oncol; 2012 Aug; 56(4):417-24. PubMed ID: 22883649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
    Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
    Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?
    Hales NW; Krempl GA; Medina JE
    Am J Otolaryngol; 2008; 29(2):113-8. PubMed ID: 18314022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot study.
    Liu J; Li C; Hu M; Lu J; Shi X; Xing L; Sun X; Fu Z; Yu J; Meng X
    Medicine (Baltimore); 2015 May; 94(17):e678. PubMed ID: 25929896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.
    Yap CS; Czernin J; Fishbein MC; Cameron RB; Schiepers C; Phelps ME; Weber WA
    Chest; 2006 Feb; 129(2):393-401. PubMed ID: 16478857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions: Comparison with diffusion-weighted imaging and FDG-PET/CT.
    Ohno Y; Kishida Y; Seki S; Yui M; Miyazaki M; Koyama H; Yoshikawa T
    J Magn Reson Imaging; 2018 Apr; 47(4):1013-1021. PubMed ID: 28799280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of FDG PET/CT for assessment of lung nodules identified during low dose computed tomography screening.
    Hadique S; Jain P; Hadi Y; Baig A; Parker JE
    BMC Med Imaging; 2020 Jun; 20(1):69. PubMed ID: 32571221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.